×
S&P 500   3,816.84 (-0.12%)
DOW   31,012.17 (+0.21%)
QQQ   283.99 (+0.16%)
AAPL   140.16 (+1.98%)
MSFT   261.53 (+1.97%)
META   163.77 (+1.92%)
GOOGL   2,242.01 (+0.08%)
AMZN   109.48 (+1.94%)
TSLA   674.88 (-3.31%)
NVDA   155.42 (-2.75%)
NIO   21.61 (-3.35%)
BABA   115.74 (-0.87%)
AMD   77.48 (-4.09%)
MU   56.15 (-2.96%)
CGC   3.53 (-2.22%)
T   20.73 (+0.58%)
GE   64.06 (-2.76%)
F   11.53 (-2.37%)
DIS   95.02 (-0.94%)
AMC   13.29 (-0.67%)
PFE   51.18 (+1.03%)
PYPL   71.49 (-0.46%)
NFLX   176.61 (-1.66%)
S&P 500   3,816.84 (-0.12%)
DOW   31,012.17 (+0.21%)
QQQ   283.99 (+0.16%)
AAPL   140.16 (+1.98%)
MSFT   261.53 (+1.97%)
META   163.77 (+1.92%)
GOOGL   2,242.01 (+0.08%)
AMZN   109.48 (+1.94%)
TSLA   674.88 (-3.31%)
NVDA   155.42 (-2.75%)
NIO   21.61 (-3.35%)
BABA   115.74 (-0.87%)
AMD   77.48 (-4.09%)
MU   56.15 (-2.96%)
CGC   3.53 (-2.22%)
T   20.73 (+0.58%)
GE   64.06 (-2.76%)
F   11.53 (-2.37%)
DIS   95.02 (-0.94%)
AMC   13.29 (-0.67%)
PFE   51.18 (+1.03%)
PYPL   71.49 (-0.46%)
NFLX   176.61 (-1.66%)
S&P 500   3,816.84 (-0.12%)
DOW   31,012.17 (+0.21%)
QQQ   283.99 (+0.16%)
AAPL   140.16 (+1.98%)
MSFT   261.53 (+1.97%)
META   163.77 (+1.92%)
GOOGL   2,242.01 (+0.08%)
AMZN   109.48 (+1.94%)
TSLA   674.88 (-3.31%)
NVDA   155.42 (-2.75%)
NIO   21.61 (-3.35%)
BABA   115.74 (-0.87%)
AMD   77.48 (-4.09%)
MU   56.15 (-2.96%)
CGC   3.53 (-2.22%)
T   20.73 (+0.58%)
GE   64.06 (-2.76%)
F   11.53 (-2.37%)
DIS   95.02 (-0.94%)
AMC   13.29 (-0.67%)
PFE   51.18 (+1.03%)
PYPL   71.49 (-0.46%)
NFLX   176.61 (-1.66%)
S&P 500   3,816.84 (-0.12%)
DOW   31,012.17 (+0.21%)
QQQ   283.99 (+0.16%)
AAPL   140.16 (+1.98%)
MSFT   261.53 (+1.97%)
META   163.77 (+1.92%)
GOOGL   2,242.01 (+0.08%)
AMZN   109.48 (+1.94%)
TSLA   674.88 (-3.31%)
NVDA   155.42 (-2.75%)
NIO   21.61 (-3.35%)
BABA   115.74 (-0.87%)
AMD   77.48 (-4.09%)
MU   56.15 (-2.96%)
CGC   3.53 (-2.22%)
T   20.73 (+0.58%)
GE   64.06 (-2.76%)
F   11.53 (-2.37%)
DIS   95.02 (-0.94%)
AMC   13.29 (-0.67%)
PFE   51.18 (+1.03%)
PYPL   71.49 (-0.46%)
NFLX   176.61 (-1.66%)

3 No-Brainer Stocks to Buy with $1000

Tuesday, April 19, 2022 | Sean Sechler
3 No-Brainer Stocks to Buy with $1000

Don't Think Twice About Adding These 3 Quality Stocks 

The beauty of investing in stocks is that anyone can get involved and start adding shares of quality companies without having a massive budget. All it takes is some research and a bit of determination to get involved in financial markets, and with many of the biggest companies in the world seeing their share prices pull back hard to start the year, there are some great deals to be had. A $1000 budget is a good starting point for new investors or for people that are interested in using some of their savings to scoop up shares of solid companies, as this will cast a wide net and allow for plenty of options to choose from.

Certain companies stand out as being worthy of adding to your portfolio at almost any level, as these market-leading businesses have been known to provide reliable gains over the long run. That’s why we’ve put together the following list of 3 no-brainer stocks to buy with $1000 below. Let’s take a deeper look at why these are great picks to consider at this time.

Target (NYSE: TGT)

If you’re looking to add a leading retailer that should put up strong numbers in any economy, targeting shares of Target makes a lot of sense. With around 2,000 stores and counting across the United States and a rapidly growing e-commerce business, this is absolutely one of the strongest stocks in retail. Target is a no-brainer thanks to the company’s established brand and the moves the company has made to expand its omnichannel sales, with older stores being renovated to serve as fulfillment centers. The company has also developed successful private brands, which grew an 18% in FY 22 to $30 billion in revenue.

Target is a prime example of a company that thrived during the pandemic, but investors should still expect decent sales growth this year even as the company faces tough comps. Finally, the fact that Target has been partnering with national brands like Ulta Beauty and leveraging its loyalty program could mean big things for the company over the long term, especially if it can continue gaining insights from its customer data. At a 16.86 P/E ratio, Target shares are much cheaper than peers like Costco and Walmart, yet another solid reason to consider adding exposure.

Microsoft (NASDAQ: MSFT)

Let’s face it, most investors are going to look into the tech sector at some point for buying opportunities, as these companies are driving both innovation and the world’s economy further. Microsoft stands out as a no-brainer pick in that sector for a few different reasons. First, the fact that it’s the world’s largest software company is a huge plus, as it tells investors that this is an established business that should continue putting up consistent earnings numbers for years to come. Products like Office, Windows, SQL Server, Xbox, and more are best-sellers that generate billions in revenue each quarter, which is certainly reassuring for conservative investors that want tech exposure.

In addition to the established cash cows, Microsoft’s enterprise cloud business Azure offers plenty of growth potential over the next decade too. In fact, the company grew Azure at an impressive 50% rate during fiscal 2021. Azure offers a great way for enterprise clients to try hybrid cloud environments since many existing companies are already using Microsoft solutions, which is a huge competitive advantage going forward. Finally, the fact that this stock has pulled back about 17% year-to-date means that investors can add exposure to one of the best companies in the world at a price well off of 52-week highs.

CVS Health (NYSE: CVS)

The health care sector is always a great place to look for investment opportunities, and that certainly holds true as we continue making our way out of a global pandemic. CVS Health stands out as a solid option given that it’s the largest pharmacy health care provider in the U.S. The company has done a lot to change its business for the better in recent years, including remodeling stores to include expanded services and acquiring one of the largest health insurers in the country, Aetna. Those moves are already paying off, and the fact that CVS is a leader in medical insurance, pharmacy benefits, and retail healthcare product should excite long-term investors.

Back in February, CVS posted better-than-expected full-year results including 12% EPS growth, which is certainly a sign of a company heading in the right direction. There’s also a lot to like about the 2.12% dividend yield here, and with a forward P/E of 12.54, it’s hard to argue against at least nibbling on shares at current levels. Healthcare spending makes up a massive portion of the overall economy, and that isn’t going to change anytime soon, making CVS Health a no-brainer.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Target (TGT)
3.8303 of 5 stars
$142.86-1.1%2.52%11.85Moderate Buy$193.04
Microsoft (MSFT)
3.2581 of 5 stars
$261.53+2.0%0.95%27.30Moderate Buy$353.36
CVS Health (CVS)
2.8539 of 5 stars
$93.32+0.1%2.36%15.50Moderate Buy$116.72
Compare These Stocks  Add These Stocks to My Watchlist 

Should you invest $1,000 in Target right now?

Before you consider Target, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Target wasn't on the list.

While Target currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

Free Email Newsletter

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:


Most Read This Week

Recent Articles

Search Headlines:

Latest PodcastHow to Profit In The Bear Market

Today, Kate is joined by a repeat guest, Rob Isbitts of Sungarden Investment Publishing. Rob specializes in ETF portfolios designed to deliver returns in any kind of market condition, including the current bear. In this conversation, Rob gives specific ideas for handling various allocations in your portfolio, and discusses how to approach inverse ETFs.

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.